Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 16.21% this year. Over the last six months, there has been a weaker performance of 20.91%. The price of ABT fallen by 17.03% during the last 30 days period. For the last 5-days stocks have improved 1.81%.
In terms of market performance, Abbott Laboratories had a somewhat regular. The highest value for the stock in the past year was $132.50 on 02/05/25, while the lowest value was $99.71 on 07/18/24.
52-week price history of ABT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Abbott Laboratories’s current trading price is -0.80% away from its 52-week high, while its distance from the 52-week low is 31.82%. The stock’s price range for this period has been between $99.71 and $132.50. The Healthcare sector company’s shares saw a trading volume of about 5.31 million for the day, which was lower than the average daily volume of 5.81 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Abbott Laboratories (ABT) has experienced a quarterly rise of 14.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 227.98B and boasts a workforce of 114000 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 116.97, with a change in price of +13.31. Similarly, Abbott Laboratories recorded 5,603,314 in trading volume during the last 100 days, posting a change of +11.27%.
ABT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ABT stands at 0.38. Similarly, the long-term debt-to-equity ratio is also 0.32.
ABT Stock Stochastic Average
As of today, the raw stochastic average of Abbott Laboratories over the last 50 days is at 95.10%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 95.10%. Further, the company’s Stochastic %K and %D values for the last 20 days were 91.25% and 88.33%, respectively.
